Rafferty Asset Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-21,244
| Closed | -$625K | – | 1087 |
|
|
2023
Q3 | $625K | Buy |
21,244
+4,980
| +31% | +$146K | ﹤0.01% | 884 |
|
|
2023
Q2 | $1.03M | Sell |
16,264
-9,050
| -36% | -$576K | 0.01% | 810 |
|
|
2023
Q1 | $1.19M | Sell |
25,314
-3,754
| -13% | -$177K | 0.01% | 757 |
|
|
2022
Q4 | $2.02M | Buy |
29,068
+18,748
| +182% | +$1.3M | 0.02% | 576 |
|
|
2022
Q3 | $1.51M | Buy |
+10,320
| New | +$1.51M | 0.02% | 572 |
|